Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 7NIH 3NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Biphenotypic, Acute 6Burkitt Lymphoma 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large B-Cell, Diffuse 3Leukemia 3Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma 2Dendritic Cell Sarcoma, Interdigitating 2Wilms Tumor 1Respiratory Distress Syndrome 1Recurrence 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia, Viral 1Neuroblastoma 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Lymphoma, AIDS-Related 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Hematologic Neoplasms 1Cytokine Release Syndrome 1Blast Crisis 1

Interventions

Vincristine 6Radiotherapy 5Prednisone 5Doxorubicin 5Cyclophosphamide 5Gemcitabine 4Cisplatin 4Rituximab 3Methotrexate 3Cytarabine 3Crizotinib 3ibritumomab tiuxetan 2Vinorelbine 2Methylprednisolone 2Etoposide 2Drug Therapy 2Dexamethasone 2merphos 1liposomal amphotericin B 1ixabepilone 1imetelstat 1Whole-Body Irradiation 1Watchful Waiting 1Vinblastine 1VAP-cyclo protocol 1Topotecan 1Stem Cell Transplantation 1Standard of Care 1Specimen Handling 1Razoxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Large-Cell, Anaplastic × Methylprednisolone × Clear all
NCT00310128 2016-02-03

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

AIDS Malignancy Consortium

Phase 2 Withdrawn
Lymphoid

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related, Lymphoma, Large-Cell, Anaplastic

NCT00109928 2014-10-01

S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma

SWOG Cancer Research Network

Phase 2 Completed
34 enrolled 9 charts
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡